Prostaglandin Analogs Dominate the Glaucoma Therapeutics Market
Prostaglandin analogs have emerged as the cornerstone of glaucoma treatment, offering effective intraocular pressure (IOP) reduction with convenient once-daily dosing. Their dominance in the Glaucoma Therapeutics Market reflects their proven efficacy, favorable safety profile, and high patient compliance. Understanding the role of these drugs is essential for stakeholders navigating this...
0 Commentarii 0 Distribuiri 88 Views 0 previzualizare